Aura Biosciences Inc. (AURA)
NASDAQ: AURA
· Real-Time Price · USD
5.92
-0.02 (-0.34%)
At close: May 23, 2025, 3:59 PM
5.91
-0.17%
After-hours: May 23, 2025, 04:08 PM EDT
-0.34% (1D)
| Bid | 5.7 |
| Market Cap | 367.07M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -94.7M |
| EPS (ttm) | -1.9 |
| PE Ratio (ttm) | -3.12 |
| Forward PE | -3.07 |
| Analyst | Strong Buy |
| Ask | 6.42 |
| Volume | 128,014 |
| Avg. Volume (20D) | 291,219 |
| Open | 5.81 |
| Previous Close | 5.94 |
| Day's Range | 5.75 - 5.99 |
| 52-Week Range | 4.34 - 12.38 |
| Beta | 0.43 |
About AURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+14.09%
Aura Biosciences shares are trading higher after H...
Unlock content with
Pro Subscription
7 months ago
+0.39%
Aura Biosciences shares are trading higher after the company announced multiple complete clinical responses following its single low-dose administration of Bel-sar in patients with non-muscle-invasive bladder cancer in its ongoing Phase 1 trial.
